Publications for Gabriel Almroth
Co-author map based on ISI articles 2007-
Journal Articles
Johanna Lönn, Gabriel Almroth, Lars Brudin and Fariba Nayeri
An antithrombin III product containing biologically active hepatocyte growth factor may be beneficial in depp ulcer infections
Cytokine, 2012, 60(2), 478-486.
|
Johanna Lönn, Faisal Shahzad, Fredrik Uhlin, Torbjörn Bengtsson, Gabriel Almroth and Fariba Nayeri
High concentration but low biological activity of hepatocyte growth factor in patients with chronic renal failure
Advances in Bioscience and Biotechnology, 2012, 3(4), 516-523.
|
Gabriel Almroth, Bengt Ekermo, Britt Åkerlind, Ann-Sofie Månsson and Anders Widell
Monitoring hepatitis C infection in a major Swedish nephrology unit and molecular resolution of a new case of nosocomial transmission.
Journal of medical virology, 2010, 82(2), 249-256.
|
Gabriel Almroth, Gösta Berlin, Bengt Andersson and Mirjana Hahn-Zoric
Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis
Scandinavian Journal of Urology and Nephrology, 2009, 43(2), 160-170.
Web of Science® Times Cited: 1 |
G. Metry, Fredrik Uhlin and Gabriel Almroth
Swedish experience of the Dialock
Scandinavian Journal of Urology and Nephrology, 2007, 41(3), 249-253.
|
Gabriel Almroth
Nysmitta av hepatit C på dialysavdelning. En fallbeskrivning.
Smittskydd, 2007, 44, 10-11.
|
O Hultgren, M Hahn-Zoric, B Andersson and Gabriel Almroth
Serum concentration of interleukin-18 is up-regulated in patients with ANCA-associated vasculitis
Autoimmunity, 2007, 40(7), 529-531.
Web of Science® Times Cited: 5 |
Gabriel Almroth, T. Axelsson, E. Müssener, Ewa Grodzinsky, Gunnar Midhagen and Per Olcén
Increased Prevalence of Anti-Gliadin IgA-Antibodies with Aberrant Duodenal Histopathological Findings in Patients with IgA-Nephropathy and Related Disorders
Upsala Journal of Medical Sciences, 2006, 111(3), 339-352.
Web of Science® Times Cited: 2 |
Gabriel Almroth, Å Lindell, H Åselius, Lars Sörén, L Svensson, Per Hultman, ERK Eribe and I Olsen
Acute glomerulonephritis associated with streptococcus pyogenes with concomitant spread of streptococcus constellatus in four rural families
Uppsala Journal of Medical Sciences, 2005, 110(3), 217-231.
Web of Science® Times Cited: 4 |
Gabriel Almroth, F Uhlin, Bengt Ekermo, Barbro Isaksson, B Kaijser, B Andersson, M Hahn-Zoric and M Sällberg
Perspectives on hepatitis B infections and the efficacy of vaccination (hepatitis B and pneumococci) in dialysis patients
Uppsala Journal of Medical Sciences, 2003, 108(1), 61-74.
Web of Science® Times Cited: 2 |
Gabriel Almroth, Bengt Ekermo, A-S. Månsson, Samuel Svensson and A. Widell
Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients: A long-term follow up (1989–January 1997)
Journal of Internal Medicine, 2002, 251(2), 119-128.
Web of Science® Times Cited: 16 |
B. G. Stegmayr, Gabriel Almroth, Gösta Berlin, I. Fehrman, J. Kurkus, R. Norda, R. Olander, G. Sterner, H. Thysell, B. Wikström and J. E. Wirén
Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis: A Swedish multi-center study
International Journal of Artificial Organs, 1999, 22(2), 81-87.
|
Per Eriksson, Gabriel Almroth, Torsten Denneberg and Folke D. Lindström
IgG2 deficiency in primary Sjögren's syndrome and hypergammaglobulinemic purpura
Clinical Immunology and Immunopathology, 1994, 70(1), 60-65.
|
Gabriel Almroth, S. Eneström, J. Hed, I. Samuelsson and P. Sjöström
Autoantibodies to leucocyte antigens in hydralazine-associated nephritis
Journal of Internal Medicine, 1992, 231(1), 37-42.
|
Gabriel Almroth, P. Sjöström, C. Svalander and D. Danielsson
Serum immunoglobulins and IgG subclasses in patients with glomerulonephritis
Journal of Internal Medicine, 1989, 225(1), 3-7.
|
Conference Articles
Fredrik Uhlin, Tayeb Nayeri, Lars Brudin, Fariba Nayeri and Gabriel Almroth
Decreased Biological Activity of Hepatocyte Growth Factor during Chronic Renal Failure
J Am Soc Nephrol, 2009.
|
Gabriel Almroth, Per Eriksson, G Berlin, B Andersson and M Hahn-Zoric
Långtidsresultat av cyklofosfamidbehandling vid ANCA-associerad systemisk vaskulit med njurengagemang
Svenska Läkaresällskapets,2004, 2004.
|
G Metry, Gabriel Almroth, M Gylling, F Uhlin, R Larsson, A Cassel, S Melander and A Fernström
The Dialock: An effective access device in a demodialysis patient with vascular problems
JASN 15 2004,2004, 2004.
|
Gabriel Almroth, Per Eriksson, G Berlin, M Hahn-Zoric and B Andersson
Cyklophosphamide pulse treatment and infections in systemic vasculitis with renal involvement
JASN 15 2004,2004, 2004.
|
Gabriel Almroth, B Ekermo, B Åkerlind, A-S Månsson and A-S Widell
Detection and prevention of hepatitis C in a nephrology unit 1997 - 2002. Further follow up and description of a case with nosocimial transmission
Kidney International 2004,2004, 2004.
|
Gabriel Almroth, T Geogrsson, E Mussener, Ewa Grodzinsky, G Malmsten and P Olcen
Increased prevalence of antigliadine IgA-antibodies in patients with IgA-nephropathy
Kidney International 2004,2004, 2004.
|
Ph.D. Theses
Ph.D., Lic. Theses
